Advertisement
Screener

NxStage Medical, Inc. Quick Ratio

NxStage Medical, Inc. Quick Ratio

  • Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2018-09-30..

Quick ratio

Overview →

Financial period ending 2018-09-30; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
Quick ratio · latest quarter(m)Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2018-09-30.

Calculation unavailable: missing inputs remain (m).

Calculation inputs

InputAmount with unitRaw financial data
Cash, securities and trade receivables(m)Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current
Current obligations58.76M USDLiabilities, Current
Cash and equivalents81.94M USDCash and Cash Equivalents, at Carrying Value
Short-term securities(m)
Customer receivables66.13M USDAccounts Receivable, after Allowance for Credit Loss, Current
Inventory · excluded from quick assets53.35M USDInventory, Net

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingCash, securities and trade receivables (USD)Current obligations (USD)Cash and equivalents (USD)Short-term securities (USD)Customer receivables (USD)Inventory · excluded from quick assets (USD)Quick ratio
2018-09-30(m)$58.76M$81.94M(m)$66.13M$53.35M(m)
2018-06-30(m)$50.39M$76.29M(m)$34.51M$50.32M(m)
2018-03-31(m)$46.46M$62.62M(m)$38.69M$52.12M(m)
2018-01-01(m)(m)(m)(m)$36.04M(m)(m)
2017-12-31(m)$47.43M$64.93M(m)$31.63M$49.21M(m)
2017-09-30(m)$46.20M(m)(m)$30.25M$50.67M(m)
2017-06-30(m)$46.51M(m)(m)$31.90M$51.23M(m)
2017-03-31(m)$47.70M(m)(m)$39.26M$48.51M(m)
2016-12-31(m)$49.26M(m)(m)$32.29M$46.84M(m)
2016-09-30(m)$48.52M(m)(m)$30.58M$46.88M(m)
2016-06-30(m)$44.98M(m)(m)$30.09M$41.31M(m)
2016-03-31(m)$43.30M(m)(m)$29.08M$39.03M(m)
2015-12-31(m)$42.74M(m)(m)$25.20M$38.39M(m)
2015-09-30(m)$44.36M(m)(m)$30.57M$42.58M(m)
2015-06-30(m)$40.86M(m)(m)$26.40M$43.37M(m)
2015-03-31(m)$43.57M(m)(m)$23.99M$45.28M(m)
2014-12-31(m)$44.76M(m)(m)$24.10M$45.40M(m)
2014-09-30(m)$46.71M(m)(m)$27.07M$47.87M(m)
2014-06-30(m)$45.69M(m)(m)$31.09M$43.35M(m)
2014-03-31(m)$44.75M(m)(m)$25.26M$40.80M(m)
2013-12-31(m)$37.61M(m)(m)$20.16M$37.80M(m)
2013-09-30(m)$37.47M(m)(m)$22.52M$37.10M(m)
2013-06-30(m)$42.96M(m)(m)$20.84M$39.35M(m)
2013-03-31(m)$42.32M(m)(m)$22.06M$36.97M(m)
2012-12-31(m)$39.23M(m)(m)$18.99M$33.50M(m)
2012-09-30(m)$34.82M(m)(m)$19.59M$34.88M(m)
2012-06-30(m)$32.49M(m)(m)$17.64M$34.67M(m)
2012-03-31(m)$32.05M(m)(m)$17.63M$34.95M(m)
2011-12-31(m)$30.80M(m)(m)$15.81M$32.77M(m)
2011-09-30(m)$35.46M(m)(m)$17.50M$35.56M(m)
2011-06-30(m)$36.84M(m)(m)$15.89M$39.21M(m)
2011-03-31(m)(m)$99.93M(m)(m)(m)(m)
2010-12-31(m)$36.39M(m)(m)$14.11M$34.95M(m)
2010-09-30(m)(m)$21.97M(m)(m)(m)(m)
2010-06-30(m)(m)$20.05M(m)(m)(m)(m)
2009-12-31(m)(m)$21.72M(m)(m)(m)(m)
2008-12-31(m)(m)$26.64M(m)(m)(m)(m)

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.